Results:
There were 178 notifications of "bacterial meningitis including meningococcal disease" in the MWHB from January 1 st 1998 to December 2002. One case could not be assigned to a time. One case of S. pneumoniae meningitis was in a 3 month old child, another was a case of meningitis a 4 year old child and one was meningitis detected in a 58 year old.
The case of H. influenzae meningitis was detected in a 3 year old. As the number of S. pneumoniae/H. influenzae is small, no further analysis is done for these organisms.
One case of TB meningitis (M. tuberculosis) was reported in 2002 in a non-national.
The proportion of N. meningitidis isolates that are "untyped" has reduced over the years, probably due to the increasing usage of better diagnostic tests such as the PCR test, performed on an EDTA blood sample or cerebrospinal fluid (CSF) at The Children's Hospital, Temple Street, Dublin. This test may detect more subclinical cases as well.
Some discrepancies in the dataset and data provided to the National Disease Surveillance Centre are apparent (2/178 cases) -these may be due to information deficits in this dataset, so the rates calculated in Table 2 and Figures 1 to 3 are based on NDSC summaries, to avoid inconsistency. The rate in both populations for all types of meningococcal disease is illustrated in Figure 1 . The rate for group B and C are presented separately to demonstrate the changing epidemiology of group C infection following the introduction of the conjugate meningococcal C vaccine in October 2000, see Figure MWHB and Ireland, 1997-2002 , including 95% confidence intervals. MWHB and Ireland, 1997-2002. MWHB and Ireland, 1997-200. Within the MWHB, the variation in meningococcal disease (MCD) between counties is striking over the period 1998 to 2002. Table 3 shows the annual incidence rates (expressed per 100,000 population) for each county. 
Seasonality (based on date of notification):
There is a typical seasonality reported to be associated with meningococcal disease (MCD). The disease is more prevalent in the months September through winter until May. This seasonality is also seen in the cases of confirmed meningococcal disease in the MWHB, see , 1998-2002. This is also the case for N. meningitidis, groups B and C, though numbers are small, see Figure 5 and Figure 6 , respectively. 
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Figure 4: Cases of meningococcal disease notified in the MWHB
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Figure 5: Cases of meningococcal disease group B notified in the MWHB
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Figure 6: Cases of meningococcal disease group C notified in the MWHB, 1998-2002. (trend line added)
Sex Distribution:
The population estimates for CCA are not as reliable as county estimates and data were missing for this category for earlier years, so further rates are based on county population. From 1998 to 2002*, ninety-nine cases of bacterial meningitis were detected in males and seventy-seven were female. The average male to female ratio was 1.29:1. This pattern varies from year to year and in different areas. A detailed description by county is provided in Table 4 . MWHB, 1998 MWHB, -2002 . From 1998 to 2002, seventy-seven cases of meningococcal disease were detected in males and sixty-four were female. The male to female ratio was 1.2:1. A detailed description by county is provided in Table 5 . From 1998 to 2002*, forty-five cases of group B meningococcal disease were detected in males and thirty-four were female. The male to female ratio was 1.32:1. This pattern was common but varied between area and year. A detailed description by county is provided in Table 6 . MWHB, 1998 MWHB, -2002 . Year  1998  2  0  1  0  1  1  4 1  1999  6  3  3  2  5  1  14 6  2000  2  2  1  1  5  2  8 5  2001   $   3  5  5  6  1  2  9 13  2002  3  3  6  5  1  1  10 9  Total  16  13  16  14  13  7  45 34 From 1998 to 2002, fourteen cases of group C meningococcal disease were detected in males and fifteen were female. The male to female ratio was 0.93:1. This pattern was also common varied between area and year but numbers are small. A detailed description by county is provided in Table 7 . MWHB, 1998 MWHB, -2002 . Age Distribution:
The age distribution of cases of bacterial meningitis provides important information about the target populations requiring interventions to prevent and control disease in the region, especially if a vaccination campaign is to be introduced in a targeted way at specific groups in the population.
In the MWHB, the number of cases of bacterial meningitis is highest in the very young, see Table 8 , but meningococcal disease represents a high proportion of all cases of bacterial meningitis (89%). There was no significant difference between the crude and age-standardised rate of bacterial meningitis in the MWHB for any of the years studied. For the prevention and control of meningococcal disease (MCD) it is important to ascertain whether the case attends a crèche or school (primary or secondary) or a college. The number of cases in young children is also high for MCD, see Table 9 . There was no significant difference between the crude and age-standardised rate of MCD in the MWHB for any of the years studied. In 2002 alone, fourteen cases were reported to have attended a crèche, six attended a primary school and two a 3 rd level college. In Table 10 , the age-specific attack rates for each age group is presented and shown graphically in Figure 7 . The incidence of MCD is highest in those aged under 20 years. The introduction of the new meningococcal C conjugate vaccine has begun to alter the epidemiology of the disease in Ireland. The incidence of disease has fallen since 2001. However, this effect is only seen for group C meningococcal disease. The rate of group B disease is unaffected, if not higher in the MWHB.
Outbreaks:
Over the period 1998 to 2002, there has been a number of outbreaks investigated. Two cases were detected in siblings in 1999 (N. meningitidis B). The same group was responsible in 2001/2002 for two cases in cousins.
Disease Classification:
The classification of disease for all notified cases are presented in Figure 8 . Meningococcal septicaemia was the most common diagnosis over the period 1998 -2002. In 2002, 19 cases of meningococcal disease were recorded as definite cases, no classification was made on five cases.
Classification of cases 1998-2002
Outcome:
Six of the 178 cases from the MWHB were reported to have died -three in Clare, three in Limerick and one in Tipperary North. There was one death in 1998, 2000 and 2001. There were three deaths in 1999. Two were group B, two were group C, one was group W135 and one was organism unknown, see Table 11 . Alternatively, some cases notified under enhanced surveillance are not denotified when diagnosis is changed.
Conclusions:
Parents and clinicians must continue to be vigilant for signs of bacterial meningitis and meningococcal disease. Prompt reporting to senior area medical officers and the Director of Public Health via telephone by clinicians of all "suspected" cases will optimise the response to disease and may prevent further spread and outbreaks of this serious and potentially fatal illness. Reporting through the weekly infectious disease notification system, and the enhanced surveillance system introduced in 1997, will assist in the descriptive epidemiology of the disease in Ireland. Cases are occurring throughout the year in the MWHB and the usual peak over winter levelled in recent time but peaked again in December 2002. The epidemiology of the disease has changed with the introduction of the meningococcal C vaccination campaign. We must continue to monitor the epidemiology of the disease for changes in age profile and classification. The young are particularly vulnerable to disease, those under five years especially but also those up to 20 years of age. The advent of molecular methods has assisted clinicians with a more rapid and sensitive means to confirm some cases of meningococcal disease. The EDTA blood sample can be taken from all age groups with suspected meningitis. The test can confirm in many instances the serogroup of the pathogen. Further typing will require the growth of the pathogen. If possible, laboratories should arrange for isolates to be transported to the Meningococcal Reference Laboratory for this investigation. Protection against N. meningitidis group C is available to these groups with a safe and effective vaccine. 
Meningococcal C Conjugate Vaccination Programme in MWHB
The objective of the Programme, introduced by the Department of Health and Children in October 2000, was to vaccinate all children and young adults up to and including 22 years of age. This vaccine is a conjugate vaccine which offers lasting immunity as opposed to the older polysaccharide vaccine which offered only shortterm immunity and is also effective in children under the age of 18 months, when meningococcal infection is most prevalent.
The Programme in the Republic of Ireland consisted of three phases.
Phase 1 
Ongoing Campaign -from January 2002
The vaccine is now part of the Primary Childhood Immunisation Schedule, being offered at 2, 4, and 6 months along with DTaP/Polio and Hib. In the Mid-Western Health Board region, an overall uptake of 72% has been achieved for the programme as a whole.
The uptake rate in Children aged 5-14 years has been especially high.
The MWHB uptake rate for children 1-4 years is above the average for the country as a whole. In the Mid Western Health Board region the overall uptake was 78% with highest uptake in those aged 6 -18 years.) The highest uptake levels in 5-17 years age group, represents children and young adults in primary and secondary school who would have largely been targeted by immunisation teams visiting the schools. The poor uptake in over 18 year olds reflects the difficulty in targeting young adults.
It is very important that every effort is made to determine whether vaccination was offered and administered to all cases of meningococcal disease notified and that all cases of apparent vaccine failure are fully investigated and notified to the National Meningococcal Reference Laboratory in The Children's Hospital, Temple St, Dublin 1.
